National and Kapodistrian University of Athens
Μελέτη της έκφρασης της ανθρώπινης ριβονουκλεάσης κ και πιθανών ισομορφών της σε διάφορους ιστούς
Abstract
dc:descriptionRecent advances in RNA biology have portrayed a central role for RNA as geneexpression regulator and the intracellular RNA metabolism constitutes an ever-rising fieldof scientific research. Tissue- and time-specific decay of RNA molecules is involved in abroad field of biological phenomena that until recently seemed to be irrelevant to theregulation of gene expression.Ribonucleases catalyze RNA catabolism and participate in a wide range ofmechanisms as splicing and quality control effectors, as protective shields against virusRNAs or as effectors of gene expression regulation. Despite their high heterogeneity,ribonucleases are considered as highly active enzymes that portray redundancy and thecapacity to act often against multiple RNA targets. They function as members of a highlycomplicated RNA decay network that is governed by rules of subtle regulation byinteracting with several cellular factors that include proteins (RNA polymerases, RNAhelicases, inhibitors and chaperones), regulatory RNAs (such as miRNAs) and other smallmolecules that guarantee their specific activity. Overall, RNases are capable of actingthrough a dynamic regulation pattern that is constantly in accordance with the cellularenvironment with a view to fulfilling the developmental and metabolic requirements thatallow cellular survival and function.Our research team has focused its research efforts on the novel ribonuclease κ(kappa) family, an orthologous protein family with representatives in all metazoans fromCnidaria to humans. Its protein counterparts portray a high conservation rate, a factdenoting a strong selective force that maintained its expression in a wide range oforganisms. Human RNase κ is expressed in all tissues and developmental stages, its gene isharbored in chromosome 17 and it retains the strict family gene organization pattern ofthree exons and two introns. It encodes the synthesis of a 98-amino acid protein thatexhibits a molecular weight of 10.98 kDa. It catalyzes the hydrolysis of ApG and ApUphosphodiester bonds, its activity is not inhibited by RI, the RNase A family inhibitor andthe formation of a disulfide bond between the cysteine 6 and 69 residues is essential for theenzyme activity.The present PhD thesis focuses on the expression analysis of human RNase κ and itspossible alternative isoforms. During this research effort a novel isoform was isolated andstudied, human RNase κ-02. According to EST data, human RNase κ is expressed in a broad range of humantissues in all developmental stages. In order to experimentally validate this expressionpattern in RNA level we performed a Northern Blot analysis in six cell lines correspondingto tissues of different origin. The results of this analysis revealed the expression of a main800 bp RNase κ transcript in all cases, a fact that verifies the expression of human RNase κin a wide range of cell types.EST data analysis also led to the retrieval of a sequence subset that harbors a minordifferentiation compared to the constitutive RNase κ isoform. Alignment of thesesequences with human RNase κ gene showed that they lack 4 consecutive bases that occursfrom a subtle alternative splicing event.In order to isolate and clone this alternative isoform we applied a combinedmolecular approach that led to the retrieval of a 540 bp cDNA clone that harbors an openreading frame of 134 aminoacids and the corresponding protein has a calculated molecularmass of 14.900 Da. This protein is encoded by the utilization of an upstream (compared toRNase κ-01) initiation codon as proposed by initiation prediction analysis. The proteinsequences alignment of the two RNase κ isoforms portrayed that they bear no similaritywithin their amino-terminal portion whereas the 63-134 RNase κ-02 portion is identical tothe 27-98 RNase κ-01 portion.In a first step we attempted to study the biochemical properties of the alternativeisoform. For this reason, we proceeded to its heterologous expression in themethylotrophic yeast Pichia pastoris system and to its partial chromatographic purification.The recombinant enzyme was used to identify the activity and the substrate specificity ofhuman RNase κ-02 against a series of RNA and DNA-RNA radiolabelled substrates. Theanalysis performed against a 30-mer RNA containing every possible dinucleotidecombination revealed that human RNase κ-02 cleaves mainly ApG and ApU phosphodiesterbonds.In order to further investigate human RNase κ-02 substrate specificity, we applied a series of 5΄-dΝdΝdΝrAdGdNdNdN-3΄ and 5΄-dΤdΤdΤrAdNdΤdΤdΤ-3΄ substrates thatcontain a single hydrolysis point. This analysis revealed that RNase κ-02 activity dependson the sequence that surrounds the hydrolyzed bond showing a higher efficiency in thepresence of dT residues. Moreover, the enzyme's activity is affected by the secondphosphodiester bond residue portraying a higher efficiency against ApG and ApT phosphodiester bonds. Last, human RNase κ-02 portrays optimum activity at pH 6.0whereas its activity seems to be hindered by the presence of NaCl in the reaction mixture.In order to determine kinetic constants for the rApG cleavage reaction, a sensitiveassay for the RNase κ-02 activity based on the relief of fluorescence quenching within adefined oligomeric substrate was used.When the substrate is cleaved, the fluorescence offluorescein is manifested. The determination of the RNase κ-02 kinetic parameters againstthe fluorescent substrate 5΄-6-FAM-TTTrAGTTT-BHQ1-3’. The continuous kinetic assay ofthe recombinant human RNases κ-01 and κ-02 revealed that despite their difference intheir amino-terminal portions, the two enzymes portray a similar affinity (Km) to theiroptimum substrate.In a next step we proceeded to the quantification of the two alternative isoformsmRNA levels in a series of human cell lines. Since the use of isoform-specific primers in abroad spectrum of RT-qPCR amplification conditions did not provide specific products, weinvented a rapid molecular approach and the quantitative analysis of the two transcriptsrelative abundance portrayed the expression of the RNase κ-02 isoform in all cases, with a ratio of RNase κ-01/ RNase κ-02 mRNA ranging from 1.45 (HEK-293 cells) to 9.06 (AGScells).It is well established that an important portion of the transcriptome has no proteincodingcapacity. Therefore, a significant question raised was whether RNase κ-02transcript is protein coding or not. Given that the RNase κ-02 amino-terminal portion (1-62aa) is different to the RNase κ-01 protein and bears no important similarities with otherknown human proteins, we proceeded to the production, purification and characterizationof a specific polyclonal antibody that recognizes only the RNase κ-02 protein isoform.Based on RNase κ-02 relative hydrophobicity, we opted for a strategy that would allow usthe considerable enrichment of highly hydrophobic proteins in cell extracts from 5 cellslines. Phase separation was followed by Western blot analysis using the purified RNase κ-02 specific polyclonal antibody. The analysis resulted in the recovery of RNase κ-02protein in the detergent-insoluble fraction and the protein was not detected in thedetergent insoluble fraction of RNase κ-02 RNAi knock-down HEK-293 cells. This resultverifies the expression of RNase κ-02 at protein level in human cells.Finally, in order to analyze the subcellular distribution of the RNase κ-02 protein weproceeded to an immunofluorescence analysis using the Κ02Ν polyclonal specific antibody.According to the performed analysis, RNase κ-02 seems to be distributed only in the cytoplasm. In order to verify the cytoplasmic distribution of human RNase κ-02 isoform weperformed RNAi mediated knock down of human RNase κ-02. In this experiment, theprotein was virtually undetected, a fact that validates the specificity of the appliedantibody.The results of this work highlight the dynamic plasticity of the existingtranscriptome by the observation that a subtle change at the mRNA level can manifest as aprofound change in protein content. The difference in the amino-terminal portion of thetwo human RNase κ isoforms could serve as a distinctive feature that would allow thedifferential action of the two enzymes in the cellular environment. For this reason, theidentification of their biological role and their mechanistic features is consideredimperative.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karousis, Evangelos
- Καρούσης, Ευάγγελος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41616